This company listing is no longer active
Indivior Crecimiento futuro
Future controles de criterios 4/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Indivior.
Información clave
40.4%
Tasa de crecimiento de los beneficios
42.4%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 20.7% |
Tasa de crecimiento de los ingresos | 11.9% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | 06 Jun 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2025 | 1,287 | 307 | 279 | 285 | 2 |
12/31/2024 | 1,134 | 250 | 157 | 213 | 4 |
12/31/2023 | 1,018 | 169 | -38 | 14 | 4 |
3/31/2023 | 947 | -50 | 23 | 35 | N/A |
12/31/2022 | 901 | -53 | -9 | -4 | N/A |
9/30/2022 | 883 | 166 | 176 | 181 | N/A |
6/30/2022 | 838 | 152 | 160 | 145 | N/A |
3/31/2022 | 818 | 166 | 175 | 189 | N/A |
12/31/2021 | 791 | 205 | 339 | 353 | N/A |
9/30/2021 | 753 | 156 | 101 | 115 | N/A |
6/30/2021 | 725 | 139 | 81 | 115 | N/A |
3/31/2021 | 674 | 95 | 39 | 42 | N/A |
12/31/2020 | 647 | -148 | -197 | -193 | N/A |
9/30/2020 | 595 | -190 | -84 | -82 | N/A |
6/30/2020 | 634 | -152 | -70 | -69 | N/A |
3/31/2020 | 700 | -95 | -131 | -130 | N/A |
12/31/2019 | 785 | 134 | 148 | 151 | N/A |
9/30/2019 | 889 | 213 | 217 | 200 | N/A |
6/30/2019 | 935 | 254 | 281 | 275 | N/A |
3/31/2019 | 988 | 248 | 401 | 413 | N/A |
12/31/2018 | 1,005 | 275 | 299 | 303 | N/A |
9/30/2018 | 1,033 | 106 | 247 | 276 | N/A |
6/30/2018 | 1,064 | 67 | 171 | 210 | N/A |
3/31/2018 | 1,083 | 71 | 231 | 260 | N/A |
12/31/2017 | 1,093 | 58 | 252 | 295 | N/A |
9/30/2017 | 1,087 | 281 | 310 | 360 | N/A |
6/30/2017 | 1,080 | 81 | 371 | 409 | N/A |
3/31/2017 | 1,065 | 65 | 331 | 370 | N/A |
12/31/2016 | 1,058 | 35 | N/A | 407 | N/A |
9/30/2016 | 1,047 | -6 | N/A | 326 | N/A |
6/30/2016 | 1,028 | 191 | N/A | 283 | N/A |
3/31/2016 | 1,021 | 201 | N/A | 252 | N/A |
12/31/2015 | 1,014 | 228 | N/A | 320 | N/A |
9/30/2015 | 1,037 | 268 | N/A | 300 | N/A |
6/30/2015 | 1,058 | 314 | N/A | 369 | N/A |
3/31/2015 | 1,085 | 361 | N/A | 530 | N/A |
12/31/2014 | 1,115 | 403 | N/A | 440 | N/A |
9/30/2014 | 1,147 | 443 | N/A | 572 | N/A |
12/31/2013 | 1,216 | 489 | N/A | 791 | N/A |
12/31/2012 | 1,339 | 607 | N/A | 866 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 2IVA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Beneficios vs. Mercado: 2IVA is forecast to become profitable over the next 3 years, which is considered above average market growth.
Beneficios de alto crecimiento: 2IVA is expected to become profitable in the next 3 years.
Ingresos vs. Mercado: 2IVA's revenue (11.9% per year) is forecast to grow faster than the German market (3.5% per year).
Ingresos de alto crecimiento: 2IVA's revenue (11.9% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if 2IVA's Return on Equity is forecast to be high in 3 years time